Ocular Therapeutix (OCUL) is up 11.7%, or $1.30 to $12.37.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCUL:
- Ocular Therapeutix Enters Quiet Period Ahead of SOL-1 Milestone
- Strong Buy Rating for Ocular Therapeutix Backed by Enhanced Regulatory Pathway and Promising Axpaxli Trial Data
- Ocular Therapeutix price target raised to $21 from $18 at BofA
- Mizuho remains bullish on EyePoint as competitor makes move for ‘Pole Position’
- Buy Rating for Ocular Therapeutix: Accelerated Axpaxli Launch and FDA Engagement Drive Positive Outlook